3 ． Experiences in Safety Measures for COVID‒19 Vaccine（ChAdOx1‒S ［recombinant］）（VaxzevriaTM Intramuscular Injection）： Focusing on the Early Post-marketing Phase Vigilance
{"title":"3 ． Experiences in Safety Measures for COVID‒19 Vaccine（ChAdOx1‒S ［recombinant］）（VaxzevriaTM Intramuscular Injection）： Focusing on the Early Post-marketing Phase Vigilance","authors":"Masako Shimoo, H. Kato, T. Tokimoto","doi":"10.3820/jjpe.27.79","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14576,"journal":{"name":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","volume":"165 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Pharmacoepidemiology\\/yakuzai Ekigaku","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3820/jjpe.27.79","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
